Marine Gross-Goupil

Centre hospitalo-Universitaire, Bordeaux

SCHOLARLY PAPERS

5

DOWNLOADS

218

TOTAL CITATIONS

2

Scholarly Papers (5)

1.

The GETUG SEMITEP Trial: De-Escalating Chemotherapy in Good-Risk Metastatic Seminoma Based on Early FDG-PET/CT

Number of pages: 25 Posted: 16 Dec 2020
Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Institut Gustave Roussy/Gustave Roussy Villejuif, Department of Medical Oncology, Saint-Louis-APHP, Faculté de Paris, University of Claude Bernard Lyon 1 - Centre Léon Bérard, Service d'Oncologie Médicale, CHU Besançon, Institut Paoli-Calmettes, Medical Oncology, Institute of Cancerology of Lorraine - Alexis Vautrin, Institut Claudius Régaud IUCT Toulouse, Centre hospitalo-Universitaire, Bordeaux, Medical Oncology, Hôpitaux Universitaires de Strasbourg, Institut de Cancérologie de l'Ouest, Centre Jean Perrin, Centre Eugène Marquis - Department of Medical Oncology, Western Cancer Institute, Clinical Research Unit, Military Hospital Begin, Department of Medical Oncology, Centre Georges-François Leclerc, Department of Medical Oncology, Centre Hospitalier Versailles André Mignot, Université Paris XI Sud - Gustave Roussy Cancer Campus, Gustave Roussy, Department of Nuclear Medicine and Endocrine Oncology, Université Paris-Saclay and Université Paris XI Sud - Gustave Roussy Cancer Campus
Downloads 71 (709,283)
Citation 1

Abstract:

Loading...

2.

Applying Sequence Clustering Methods to Characterize Healthcare Pathways of Patients at Different Prostate Cancer Stages in the French Nationwide Healthcare Database

Number of pages: 25 Posted: 23 Jun 2022
Institut Polytechnique de Paris - ENSTA Paris, University of Bordeaux, University of Bordeaux, Centre hospitalo-Universitaire, Bordeaux, University of Bordeaux, University of Bordeaux, University of Bordeaux, University of Bordeaux, University of Bordeaux and University of Bordeaux - Bordeaux PharmacoEpi
Downloads 60 (775,285)
Citation 1

Abstract:

Loading...

Prostate cancer, healthcare pathway, clustering, machine learning, SNDS

3.

Gemcitabine Plus Platinum-Based Chemotherapy in Combination with Bevacizumab for Kidney Metastatic Collecting Duct and Medullary Carcinomas: Results of a Prospective Phase II Trial (BEVABEL- GETUG/AFU24)

Number of pages: 22 Posted: 28 Feb 2023
Université Paris Cité, University of Claude Bernard Lyon 1 - Centre Léon Bérard, Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris - Hôpital Henri-Mondor, Institut de cancérologie Strasbourg Europe(ICANS), Centre hospitalo-Universitaire, Bordeaux, Institut Claudius Régaud IUCT Toulouse, Centre François Baclesse - Department of Medical Oncology, René Gauducheau, Centre Eugène Marquis - Department of Medical Oncology, Institut Paoli-Calmettes, Hôpital d'Instruction des Armées Bégin, ARTIC: Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie, Université Paris Cité, UNICANCER, Université Paris Cité, Université Paris Cité, Université Paris-Saclay and Université Paris Cité
Downloads 33 (1,005,071)

Abstract:

Loading...

Adult, rare tumors, renal medullary carcinoma (RMC), collecting duct carcinoma, bevacizumab, chemotherapy

4.

Gastrointestinal Metastases in Renal Cell Carcinoma: A Retrospective Multicenter GETUG (Groupe D’Étude Des Tumeurs Uro-Génitales) Study

Number of pages: 17 Posted: 28 Nov 2023
University Hospital of Tours, University of Claude Bernard Lyon 1 - Centre Léon Bérard, Bordeaux University Hospital, Institut Paoli-Calmettes, Université Paris XI Sud - Institut Gustave Roussy/Gustave Roussy Villejuif, Centre Eugène Marquis - Department of Medical Oncology, IUCT Oncopole - Institut Universitaire du Cancer de Toulouse, Institut de cancérologie Strasbourg Europe(ICANS), Bergonié Institute, Jean Minjoz Hospital, University Hospital of Tours, Service d'Oncologie Médicale, CHU Besançon, Bergonié Institute, IUCT Oncopole - Institut Universitaire du Cancer de Toulouse, Université Paris-Saclay, Institut Paoli-Calmettes, Centre hospitalo-Universitaire, Bordeaux and University Hospital of Tours
Downloads 32 (1,015,670)

Abstract:

Loading...

Renal Cell Carcinoma, Gastrointestinal Tract, Metastasis, Gastrointestinal Hemorrhage

5.

PD-L1 Expression and its Prognostic Value in Metastatic Papillary Renal Cell Carcinoma: Results from a GETUG Multicenter Retrospective Cohort

Number of pages: 19 Posted: 19 Mar 2024
University of Padua - University Hospital, University of Nantes, University Hospital of Tours, University Hospital of Tours, Hospital Center University Pontchaillou, Institut de Cancérologie de l'Ouest, IUCT Oncopole - Institut Universitaire du Cancer de Toulouse, Centre Eugène Marquis - Department of Medical Oncology, Université Paris Cité, Centre hospitalo-Universitaire, Bordeaux, University Hospital of Tours, Institut Paoli-Calmettes, René Gauducheau, University Hospital of Tours, La Milétrie University Hospital, Institut de Cancérologie Lucien Neuwirth (ICLN), Centre Georges-François Leclerc, University of Lille II - Centre Oscar Lambret, Université Paris-Saclay, Université de Tours and University Hospital of Tours
Downloads 22 (1,133,098)

Abstract:

Loading...

papillary renal cell carcinoma, immune checkpoints, PD-L1, angiogenesis